Bioscience news and upcoming events
News
Lonza Expands its TheraPEAK® Product Portfolio with the Addition of AmpliCell® Cytokine Range and TheraPEAK® 293-GT® Medium
With the launch of TheraPEAK® AmpliCell® Cytokines and TheraPEAK® 293-GT® Medium Lonza expands its GMP solutions for cell and gene therapy.
Introducing next-generation 4D-Nucleofector® LV Unit PRO for improved electroporation in GMP manufacturing
Designed to deliver clinically relevant cargos, this unit builds on Lonza’s well-established non-viral large-scale transfection platform, serving as a scalable and reproducible platform for a seamless translation from research to GMP manufacturing.
Renowned Champalimaud Foundation selects MODA-ES® Platform
Through the installation, the institute plans to improve and streamline the cell therapy manufacturing process
Lonza's Rapid PyroCell® Monocyte Activation Test Systems make rabbit-free pyrogen testing faster, easier, and more efficient
Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit
Lonza launches Nebula® Absorbance Reader for streamlined endotoxin and pyrogen testing
The new Lonza Nebula® Absorbance Reader provides QC labs with a fully optimized absorbance reader. It features high-performance optics and monochromator-based wavelength selection to ensure precise and accurate measurements of endotoxin levels, and reduces the risk of false positives or negatives.
Lonza launches TheraPRO® CHO Media System to improve productivity and quality in therapeutic protein manufacture
Lonza just launched a new GS-CHO cell culture media system to optimize production of therapeutic monoclonal antibodies and recombinant proteins: The TheraPRO® CHO Media System.
Lonza launches TheraPEAK® T-VIVO® Cell Culture Medium to accelerate cell therapy development
Lonza launches the TheraPEAK® T-VIVO® Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing.
New Lonza webinar – 'Taking the leap into an MES from a CEO’s perspective'
In this free 45-minute webinar, gain exclusive insight into the lessons the CEO of Exela® Pharma Sciences learned while implementing a Manufacturing Execution System (MES), and the lasting impact it will have on the company.
Upcoming events
High-content CRISPR Screening Conference
18 - 19 March 2026
Austria Trend Hotel Savoyen
Vienna, Austria
Booth# TBC
Conference
CRISPR screens have become a primary discovery engine in modern biology as well as a key tool in drug discovery. This conference features technologies that link CRISPR perturbation screens to high-content read-outs.
CRISPRMED26
14 - 16 April 2026
Øksnehallen
Copenhagen, Denmark
Booth# A4
Conference
This event will bring the global CRISPR Medicine community to the forefront, with focus on the most critical topics in the therapeutic gene-editing field: Tools, delivery, safety, functional genomics, standards and regulations, pre-clinical research and clinical trials.
BioProcess International Europe 2026
27 - 30 April 2026
Vienna Congress & Convention Center
Vienna, Austria
Booth# 519
Conference
Go beyond theory: Cutting-edge science, strategies and digital tools to accelerate your journey from molecule to market for mAbs, Biologics and ATMPs.
ESGCT - 33rd Annual Congress
27 - 30 October 2026
CCH - Congress Center Hamburg
Hamburg, Germany
Booth# TBC
Conference
The ESGCT Annual Congress brings together experts, researchers, and professionals in gene and cell therapy. The Congress is an invaluable platform for sharing the latest research, advancements and innovations in the field.